 Funding provides for the acceleration of its internal growth strategy and the continued development of Reshapes weight-loss portfolio SAN CLEMENTE, CA ACCESSWIRE June 30, 2021 ReShape Lifesciences Inc. NASDAQ:RSLS, a global physician-led weight-loss and metabolic health solutions company, today provided additional information about its previously announced warrant exercise agreement with existing accredited investors for approximately 46 million in gross proceeds. The company is currently anchored by the Lap-Band System with over 1,000,000 worldwide placements and the companys recently launched reshapecareTM virtual health program, both reimbursed through major insurance carriers. 